US Hospitals Accelerate Intuitive Surgical Robotic Placements Despite Procedure Dip

Key Facts

1Intuitive Surgical is seeing a significant acceleration in da Vinci robotic system placements in U.S. hospitals despite a temporary dip in current procedures.

2Recurring revenue from instruments and services accounts for 85% of total revenue, making the growth of the installed base critical.

In a move reflecting healthcare institutions' confidence in the future of robotic surgery, Intuitive Surgical is seeing a significant acceleration in da Vinci system placements across U.S. hospitals. This capital expansion comes despite a temporary dip in current surgical procedures, as healthcare providers bet on long-term future demand. According to reports, this trend strengthens the company's installed base, which is vital for the sustainability of its advanced technology business model.

These new installations are of paramount strategic importance as recurring revenue from instruments and services accounts for approximately 85% of the company's total revenue. Based on market facts, growing the installed base ensures stable and continuous cash flows, independent of the volatility of one-time hardware sales. This robust capital investment by hospitals indicates an optimistic outlook that transcends current operational challenges in the healthcare sector.

In terms of market performance, ISRG stock stood at $373.57, while 0R29.L closed at $375.17 as of the August 24, 2026 close. Investors are monitoring support and resistance levels around the $373.48 to $384.06 range recorded in recent sessions. With no direct healthcare sector catalysts in the upcoming economic calendar, focus remains on the company's ability to maintain the pace of new placements to drive high-margin revenue growth.

Sources:

Trefis